Public Hearing | Mixed
Event Title
Considerations for Potential Future Therapeutic Use of Psychedelic Drugs Public Hearing
September 14, 2026
- Date:
- September 14, 2026
- Time:
- 12:30 p.m. - 4:30 p.m. ET
Location
FDA’s White Oak Campus, Building 31, Room 1503 - Great Room
10903 New Hampshire Avenue, Silver Spring, Maryland 20993
FDA Campus Information (e.g., local airports, directions, and local hotels)
Background
The U.S. Food and Drug Administration (FDA) is announcing a public hearing, held in collaboration with federal partners, to obtain feedback and perspectives on issues associated with the potential future therapeutic use of drug products containing a psychedelic drug substance in supervised and supportive settings.
Written Comments
Written comments must be submitted to the Federal Register :: Considerations for Potential Future Therapeutic Use of Psychedelic Drugs; Public Hearing; Request for Comments electronic filing system by 11:59 p.m. ET on October 5, 2026.
Registration and Webcast Information
Registration is now closed. Individuals who have not yet registered may view the meeting live on the FDA’s YouTube channel on Monday, September 14, at 12:30 p.m. ET.
Event Materials
The agenda, including the public commenter list, is available at Agenda | Part 15 Hearing on Considerations for Potential Future Therapeutic Use of Psychedelic Drugs.
Questions
Email questions to PsychedelicsHearing@fda.hhs.gov.
More Information
How FDA is supporting the development of psychedelic drugs